The study of the respiratory system microbiome is a burgeoning field that has recently garnered significant attention.

A newborn baby who died at Craigavon Area Hospital after developing infections while in the womb would likely not have survived through earlier pre-birth intervention due to the “severity” of her ...

Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of ...

VANCOUVER, BC, Nov. 18, 2025 /CNW/ - Light AI Inc. ("Light AI" or the "Company") (CBOE CA: ALGO) (FSE: 0HC) (OTCQB: OHCFF), a healthcare technology company developing AI-powered diagnostic tools, ...

Like all living things, bacteria adapt to survive. Over time, bacteria have been developing resistance to common antibiotics ...

A research team from Trinity College Dublin has unveiled a new approach to vaccination that could redefine how we protect ...

Acquisition adds complementary dermatology product to the Pelthos portfolio anchored by ZELSUVMI™Xepi is a novel FDA-approved topical treatment ...

Proceeds will support the growth of Biofrontera’s commercial photodynamic therapy (PDT) platform, and expansion of Ameluz® into additional indications.

Pelthos Therapeutics acquires U.S. rights to Xepi Cream and raises $18 million to fund its relaunch and expand dermatology ...

A 15-year retrospective study in adults admitted to the intensive care department at Donostia University Hospital has revealed crucial insights into invasive Streptococcus pyogenes (iGAS) infections.